Noliprel Forte Arginine (Indapamide, Perindopril Arginine)

Noliprel Forte Arginine is indicated for conditions within the hypertension therapeutic pathway.

• Hypertension: lowers systolic and diastolic blood pressure, helping achieve target levels.
• Essential hypertension: provides consistent blood pressure control in patients with primary hypertension.
• Secondary hypertension: may be used as part of combination therapy to manage blood pressure when caused by other conditions.

• Perindopril, an angiotensin‑converting enzyme (ACE) inhibitor, blocks the conversion of angiotensin I to the vasoconstrictor angiotensin II, leading to vasodilation and reduced aldosterone‑mediated sodium retention. Indapamide, a thiazide‑like diuretic, inhibits NaCl reabsorption in the distal convoluted tubule, promoting natriuresis and diuresis. The combined actions decrease peripheral vascular resistance and plasma volume, producing an additive antihypertensive effect.

Common and serious adverse reactions have been reported with the combination of perindopril and indapamide.

Common Side Effects

• Dizziness: sensation of light‑headedness, especially after standing.
• Headache: mild to moderate intensity.
• Cough: dry, non‑productive cough.
• Fatigue: general feeling of tiredness.
• Electrolyte imbalance: mild changes in potassium or sodium levels.
• Increased urination: due to diuretic effect.

Serious or Rare Side Effects

• Angioedema: swelling of face, lips, tongue or airway.
• Severe hypotension: marked drop in blood pressure causing fainting.
• Acute kidney injury: sudden reduction in renal function.
• Hyperkalemia: dangerously high potassium levels.
• Blood disorders: neutropenia or agranulocytosis.
• Liver dysfunction: elevated transaminases.

When prescribing Noliprel Forte Arginine, clinicians should consider several precautionary measures to ensure patient safety.

• Renal function: assess kidney function before initiating therapy and monitor periodically.
• Electrolytes: check serum potassium and sodium levels, especially in patients on other diuretics.
• Pregnancy: avoid use unless clearly needed; benefits must outweigh potential risks.
• Concomitant ACE inhibitors: do not combine with other ACE inhibitors or ARBs to prevent additive effects.
• Hyperkalemia risk: monitor in patients with diabetes or those receiving potassium‑sparing agents.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and light.

Noliprel Forte Arginine may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Other ACE inhibitors or ARBs: combined use can cause excessive hypotension and renal impairment.
• Potassium‑sparing diuretics or supplements: increase risk of hyperkalemia.
• NSAIDs (e.g., ibuprofen, naproxen): may reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely)

• Lithium: diuretic component can raise lithium levels, requiring serum monitoring.
• Antidiabetic drugs: may enhance hypoglycaemic effect, necessitating glucose monitoring.
• Thiazide‑type diuretics: additive diuretic effect may cause electrolyte disturbances.